SABIC (2010) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Mar, 2026Executive summary
Q3 2024 revenue rose to $9.83 billion (SR 36.88 billion), up 3% year-over-year, with stable EBITDA of $1.52 billion and a significant net income turnaround, supported by portfolio optimization and sustainability initiatives.
Major divestments included the sale of Hadeed and ALBA shares, with recognized losses and reclassification as discontinued operations.
Sustainability and innovation efforts were recognized with awards and milestones in recycling and solar technology.
Financial highlights
Q3 2024 revenue reached $9.83 billion, up 3% sequentially and year-over-year; EBITDA was $1.52 billion, with a margin of 15.4%.
Net income for Q3 was $268 million (SR 1.76 billion), a sharp improvement from a loss in Q3 2023.
Year-to-date EBITDA totaled $4.24 billion, and net income from continued operations for nine months was about $1 billion, up 40% year-over-year.
Free cash flow for Q3 2024 was $1.05 billion, and cash flow from operations was $1.75 billion.
Gross profit for Q3 2024 was SR 7.0 billion, with a gross margin of 19.0%.
Outlook and guidance
2024 global GDP growth is forecast at 2.7%, with monetary easing and stable economic growth expected.
CapEx for 2024 is projected at $3.3–$3.9 billion, reflecting disciplined capital management and growth investments.
Final sale consideration for Hadeed is pending, and ALBA share sale is expected to close within twelve months.
Latest events from SABIC
- Adjusted profits remained resilient and free cash flow rose 17% despite margin pressure.2010
Q4 20255 Mar 2026 - Q2 2024 delivered strong profit growth, portfolio optimization, and top-tier sustainability progress.2010
Q2 20242 Feb 2026 - EBITDA rose 2% to $5.2B as net income rebounded and dividends reached $2.72B.2010
Q4 20247 Jan 2026 - Q1 2025 saw stable revenue, narrowed losses, improved EBITDA, and ongoing transformation efforts.2010
Q1 202525 Dec 2025 - Adjusted EBITDA jumped 40% in Q2 2025, but net loss was $1.1B from major impairments.2010
Q2 202523 Nov 2025 - Revenue dipped but EBITDA and free cash flow were resilient as transformation gains continued.2010
Q3 20253 Nov 2025